Treatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues.
AuthorsHendry, Jolyon H
AffiliationCancer Research Campaign Department of Experimental Radiation Oncology, Paterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, UK.
MetadataShow full item record
AbstractA published collation of data for control of head and neck cancer in over 4500 patients has been subjected to direct analysis to deduce dose-response, fractionation, and time parameters. The analysis confirms the presence of a significant time factor of the order of 0.5-0.6 Gy/day, deduced previously using various assumptions and normalisation procedures. In addition, the dose-response curve was characterised by Da = 29 Gy which contributed to long "effective" doubling times being deduced for tumour clonogens in the patient population as a whole. Some late-reacting normal tissues also show significant time factors, and furthermore, their dose-response curves are in general steeper than for tumours. Hence, care should be taken in accelerating treatments to improve local control, if the treatments are truly at tolerance regarding late-appearing major complications.
CitationTreatment acceleration in radiotherapy: the relative time factors and dose-response slopes for tumours and normal tissues. 1992, 25 (4):308-12 Radiother Oncol
JournalRadiotherapy and Oncology
- Fractionation sensitivities and dose-control relations of head and neck carcinomas: analysis of the randomized hyperfractionation trials.
- Authors: Stuschke M, Thames HD
- Issue date: 1999 May
- The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
- Authors: Wu Q, Manning M, Schmidt-Ullrich R, Mohan R
- Issue date: 2000 Jan 1
- Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
- Authors: Fu KK, Pajak TF, Marcial VA, Ortiz HG, Rotman M, Asbell SO, Coia LR, Vora NL, Byhardt R, Rubin P
- Issue date: 1995 Jun 15
- Apparent rates of proliferation of acutely responding normal tissues during radiotherapy of head and neck cancer.
- Authors: Fowler JF
- Issue date: 1991 Nov
- [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
- Authors: Kiprian D, Jarząbski A, Pawłowska B, Michalski W, Kawecki A
- Issue date: 2011 Sep